Get the Stockscreener App
1.88
1.05%
-0.02
Acumen Pharmaceuticals Inc stock is traded at $1.88, with a volume of 282.57K.
It is down -1.05% in the last 24 hours and up +0.00% over the past month.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
See More
Previous Close:
$1.90
Open:
$1.86
24h Volume:
282.57K
Relative Volume:
0.86
Market Cap:
$113.88M
Revenue:
-
Net Income/Loss:
$-64.86M
P/E Ratio:
-1.6786
EPS:
-1.12
Net Cash Flow:
$-55.66M
1W Performance:
-14.93%
1M Performance:
+0.00%
6M Performance:
+88.70%
1Y Performance:
-40.69%
1-Day Range:
$1.735
$1.92
1-Week Range:
$1.735
$2.24
52-Week Range:
$0.8551
$3.36
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
Name
Acumen Pharmaceuticals Inc
Sector
Industry
Phone
617-344-4190
Address
1210-1220 WASHINGTON STREET, NEWTON
Compare ABOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
1.88 | 115.09M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Initiated | Citigroup | Buy |
| Jul-26-24 | Initiated | Citigroup | Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Jul-20-23 | Resumed | BofA Securities | Buy |
| May-18-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-15-22 | Initiated | BTIG Research | Buy |
| Jun-30-22 | Initiated | H.C. Wainwright | Buy |
| Jan-21-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-26-21 | Initiated | BofA Securities | Neutral |
| Jul-26-21 | Initiated | Credit Suisse | Outperform |
| Jul-26-21 | Initiated | Stifel | Buy |
| Jul-26-21 | Initiated | UBS | Buy |
View All
Acumen Pharmaceuticals Inc Stock (ABOS) Latest News
Applying chart zones and confluence areas to Acumen Pharmaceuticals Inc.July 2025 Institutional & Fast Entry and Exit Trade Plans - newser.com
Is Acumen Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Acumen Pharmaceuticals Inc expected to post a loss of 60 cents a shareEarnings Preview - TradingView
Using data models to predict Acumen Pharmaceuticals Inc. stock movementQuarterly Performance Summary & Community Trade Idea Sharing Platform - newser.com
Will Acumen Pharmaceuticals Inc. stock go up soonWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Is Acumen Pharmaceuticals Inc. stock recession proofMarket Trend Report & AI Enhanced Trading Signals - newser.com
Can Acumen Pharmaceuticals Inc. rally from current levelsWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
How Acumen Pharmaceuticals Inc. stock performs in high volatility marketsCPI Data & Weekly Breakout Stock Alerts - newser.com
{固定前缀} What analysts say about Acumen Pharmaceuticals Inc stockSector Performance Drivers & Big Gains Small Trading - earlytimes.in
Will a bounce in Acumen Pharmaceuticals Inc. offer an exitJuly 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
Acumen Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Update & Real-Time Chart Pattern Alerts - newser.com
Is Acumen Pharmaceuticals Inc. stock a buy in volatile marketsMarket Activity Summary & High Conviction Buy Zone Alerts - fcp.pa.gov.br
Tools to monitor Acumen Pharmaceuticals Inc. recovery probabilityPortfolio Return Report & Precise Trade Entry Recommendations - newser.com
Reversal indicators forming on Acumen Pharmaceuticals Inc. stockPortfolio Performance Report & Daily Volume Surge Signals - newser.com
Acumen Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 12, 2025 - The Manila Times
Acumen Pharmaceuticals (NASDAQ: ABOS) sets Nov. 12 webcast at 8 a.m. ET and call - Stock Titan
Acumen Pharmaceuticals (ABOS) to Release Earnings on Tuesday - MarketBeat
Will Acumen Pharmaceuticals Inc. stock continue dividend increasesWeekly Trade Report & AI Based Buy and Sell Signals - fcp.pa.gov.br
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference - The Manila Times
Acumen Pharma (NASDAQ: ABOS) at Stifel Healthcare Conference; webcast 4:40 ET - Stock Titan
Published on: 2025-11-03 03:22:41 - newser.com
How to forecast Acumen Pharmaceuticals Inc. trends using time seriesPrice Action & Daily Stock Momentum Reports - newser.com
When is the best time to exit Acumen Pharmaceuticals Inc.2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Acumen Pharmaceuticals Inc Stock Analysis and ForecastMarket Volatility Update & Free Stock Predictions and Analysis - earlytimes.in
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Acumen Pharmaceuticals Inc Stock (ABOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):